Sabra Renews and Extends its Credit Facility
Summary:
-
$1.0 billion unsecured revolving credit facility maturing inJanuary 2027 , with two additional six-month extension options -
$430 million USD unsecured term loan maturing inJanuary 2028 -
$150 million CAD (~$110 million USD ) unsecured term loan maturing inJanuary 2028 - Pricing is consistent with the prior credit facility and will be based on adjusted SOFR/CDOR plus a spread of 77.5-145 bps for the revolver, and 85-165 bps for the term loans. At closing, the spread for Sabra’s borrowings under the revolver and term loans were 110 bps and 125 bps, respectively.
-
Additionally, an accordion feature affords Sabra the optionality to seek an increase in the capacity of the credit facility to
$2.75 billion , subject to customary terms and conditions.
“We are pleased to renew our credit facility, which improves our debt maturity profile by pushing our nearest material maturity to
About Sabra
View source version on businesswire.com: https://www.businesswire.com/news/home/20230105005110/en/
Investor & Media Inquiries: 1-888-393-8248 or investorinquiries@sabrahealth.com
Source: